Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	368.09	187.65	40.09
Graham Fair Price	49.84	32.53	21.71
PEG	-97.32	0.01	-0.52
Price/Book	16.11	5.13	4.42
Price/Cash Flow	-17.56	42.60	51.67
Prices/Earnings	-69.44	-5.40	17.66
Price/Sales	-5.10	13.47	14.19
Price/FCF	-17.56	42.60	51.67
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.73	0.77	0.71
Operating Margin	185.28	-0.65	0.23
ROA	222.05	-0.07	0.02
ROE	0.06	-0.24	279.89
ROIC	0.03	-0.09	225.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	4039.17
Dividends QOQ	-0.01	0.05	383.01
EBIT QOQ	-0.39	-3.68	-855.06
EPS QOQ	-0.34	-3.90	-1038.77
FCF QOQ	0.20	0.08	-58.19
Revenue QOQ	< 0.005	-0.06	562.73
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.95	107.45	39.64
Days Sales Outstanding (DSO)	58.95	62.85	6.61
Inventory Turnover	1.17	0.84	-28.39
Debt/Capitalization	0.52	0.59	12.83
Quick Ratio	1.06	0.82	-22.03
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.30	14.06	-23.12
Cash	5.82	4.86	-16.52
Capex	-0.17	-0.08	51.12
Free Cash Flow	1.57	1.70	8.28
Revenue	5.70	5.36	-5.94
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.43	1.08	-24.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.32	34.76	449.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating